Top Markets
#1 KOGE KOGE +167.80%
#2 Siren Siren +60.63%
#3 GoPlus Security GoPlus Security +40.17%
#4 Tutorial Tutorial +30.33%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.18%
#6 SkyAI SkyAI +16.56%
#7 Status Status +14.98%
#8 Pons Pons +14.51%
#9 Verus Coin Verus Coin +13.17%
#10 Talus Network Talus Network +10.97%
Coin of the day
KOGE KOGE
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Classement en actions #33871
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Prix de l'action
$0.5475
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$6.71M
Changement (1 jour)
5.57%
Changement (1 an)
-
Pays
US
Échange 20/20 Biolabs Inc. (AIDX)

Catégorie

Healthcare
Bénéfices pour 20/20 Biolabs Inc. (AIDX)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de 20/20 Biolabs Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour 20/20 Biolabs Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
HCA Healthcare, Inc. HCA Healthcare, Inc.
HCA Healthcare, Inc.
HCA.US
$9.87B -
US
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
FRE.DE
- -
DE
Dr. Sulaiman Al Habib Medical Services Group Company Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company
4013.SR
$687.82M -
SA
Tenet Healthcare Corporation Tenet Healthcare Corporation
Tenet Healthcare Corporation
THC.US
$3.87B -
US
IHH Healthcare Berhad IHH Healthcare Berhad
IHH Healthcare Berhad
5225.KL
- -
MY